Overview Ceftaroline China Pharmacokinetics Study Status: Completed Trial end date: 2012-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of ceftaroline in Chinese healthy subjects following single and multiple intravenous doses. Phase: Phase 1 Details Lead Sponsor: AstraZenecaPfizerCollaborator: Forest LaboratoriesTreatments: Ceftaroline fosamilCephalosporins